Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
5 Years Aggregate
CFO
$-281.52 Mln
EBITDA
$--
Net Profit
$-293.74 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Gamida Cell (GMDAQ)
| -- | -- | -- | -- | -- | -- | -- |
|
BSE Sensex*
| -9.1 | 1.1 | 1.2 | -4.8 | 5.8 | 6.6 | 10.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Gamida Cell (GMDAQ)
Gamida Cell Ltd. researches, develops, and commercializes cell therapies. The company offers Omisirge (omidubicel-onlv), a cell therapy for use in treatment of patients with hematologic malignancies and severe aplastic anemia. Its product candidate... includes GDA-201, an investigational NK cell-based cancer immunotherapy, for the treatment of hematologic and solid tumors, as well as to treat follicular and diffuse large B-cell lymphomas which is in phase 1 of phase1/2 clinical trial. The company was incorporated in 1998 and is based in Boston, Massachusetts. Read more
-
President, CEO & Director
Ms. Abigail L. Jenkins M.S.
-
Chief Financial Officer
Ms. Mary Theresa Coelho M.B.A.
-
Headquarters
Boston, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Gamida Cell (GMDAQ)
What is the current share price of Gamida Cell Ltd (GMDAQ) Today?
The share price of Gamida Cell Ltd (GMDAQ) is $0.02 (NASDAQ) as of 24-May-2024 12:55 EDT. Gamida Cell Ltd (GMDAQ) has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Gamida Cell Ltd (GMDAQ)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2023 |
-0.94 |
-20.08 |
2022 |
-1.21 |
-11.99 |
2021 |
-- |
-- |
2020 |
-- |
-- |
2019 |
-- |
-- |
What is the 52 Week High and Low of Gamida Cell Ltd (GMDAQ)?
The 52-week high and low of Gamida Cell Ltd (GMDAQ) are Rs -- and Rs -- as of 27-Aug-2026.
What is the market cap of Gamida Cell Ltd (GMDAQ)?
Gamida Cell Ltd (GMDAQ) has a market capitalisation of -- as on 24-May-2024. As per SEBI classification, it is a company.
Should I invest in Gamida Cell Ltd (GMDAQ)?
Before investing in Gamida Cell Ltd (GMDAQ), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.